These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 8959347)

  • 1. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.
    Nagpal S; Thacher SM; Patel S; Friant S; Malhotra M; Shafer J; Krasinski G; Asano AT; Teng M; Duvic M; Chandraratna RA
    Cell Growth Differ; 1996 Dec; 7(12):1783-91. PubMed ID: 8959347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of tazarotene action in psoriasis.
    Duvic M; Nagpal S; Asano AT; Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid receptor-nuclear factor-interleukin 6 antagonism. A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker.
    DiSepio D; Malhotra M; Chandraratna RA; Nagpal S
    J Biol Chem; 1997 Oct; 272(41):25555-9. PubMed ID: 9325272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model.
    Jean J; Soucy J; Pouliot R
    Tissue Eng Part A; 2011 Jul; 17(13-14):1859-68. PubMed ID: 21417679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin.
    Nagpal S; Patel S; Jacobe H; DiSepio D; Ghosn C; Malhotra M; Teng M; Duvic M; Chandraratna RA
    J Invest Dermatol; 1997 Jul; 109(1):91-5. PubMed ID: 9204961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.
    Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J
    J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non-coding RNA, PRINS.
    Szegedi K; Sonkoly E; Nagy N; Németh IB; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M
    Exp Dermatol; 2010 Mar; 19(3):269-78. PubMed ID: 20377629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte differentiation induced by calcium, phorbol ester or interferon-gamma elicits distinct changes in the retinoid signalling pathways.
    Karlsson T; Vahlquist A; Törmä H
    J Dermatol Sci; 2010 Mar; 57(3):207-13. PubMed ID: 20122816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
    Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunofluorescence localization of nuclear retinoid receptors in psoriasis versus normal human skin.
    Karlsson T; Rollman O; Vahlquist A; Törmä H
    Acta Derm Venereol; 2004; 84(5):363-9. PubMed ID: 15370702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes.
    Thacher SM; Nagpal S; Klein ES; Arefieg T; Krasinski G; DiSepio D; Agarwal C; Johnson A; Eckert RL; Chandraratna RA
    Cell Growth Differ; 1999 Apr; 10(4):255-62. PubMed ID: 10319995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the expression of RXRalpha in patients with psoriasis vulgaris.
    Feng S; Lin L; Wu Q; Zhou W; Shao C
    Eur J Dermatol; 2006; 16(1):33-8. PubMed ID: 16436339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
    Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
    Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
    Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
    Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of psoriasis.
    Kadunce DP; Krueger GG
    Dermatol Clin; 1995 Oct; 13(4):723-37. PubMed ID: 8785878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin.
    Nagpal S; Patel S; Asano AT; Johnson AT; Duvic M; Chandraratna RA
    J Invest Dermatol; 1996 Feb; 106(2):269-74. PubMed ID: 8601727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP-2 in the expression of human keratinocyte genes.
    Oyama N; Takahashi H; Tojo M; Iwatsuki K; Iizuka H; Nakamura K; Homma Y; Kaneko F
    Arch Dermatol Res; 2002 Aug; 294(6):273-80. PubMed ID: 12192491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.